The Science to Prevail
We are developing disease-modifying gene therapies for patients with Parkinson’s disease and other neurodegenerative disorders.
learn moreverb \ pre·vail \ pre-‘vāl
To prove more powerful than opposing forces. To be victorious. To gain ascendance through strength. To triumph. We are developing disease-modifying gene therapies to prevail against neurodegenerative diseases.
Prevail Therapeutics is applying precision medicine to the development of gene therapies to slow or stop disease progression in patients with Parkinson’s disease and other neurodegenerative disorders.
We are leveraging recent breakthroughs in human genetics and the transformative success of AAV-based gene therapy to achieve this goal.
learn more
We are building a team dedicated to dramatically improving treatment outcomes for patients with neurodegenerative diseases. Learn more about career opportunities at Prevail.
join our teamPrevail Therapeutics featured on “Behind the Mystery”, a recurring series by The Balancing Act that is devoted to advocating for rare and genetic diseases alongside patients and their advocates.
The ground-breaking episode, “Behind the Mystery of Gaucher Disease”, made its debut on October 2, 2023 on Lifetime TV. It covers important topics ranging from exploring current treatment options, such as enzyme replacement and oral therapies, to the future of research, including gene transfer therapies that could reduce the need for frequent interventions to improve quality of life.